Boston Scientific Corp
NYSE:BSX

Watchlist Manager
Boston Scientific Corp Logo
Boston Scientific Corp
NYSE:BSX
Watchlist
Price: 104.385 USD 0.14% Market Closed
Market Cap: 154.4B USD

Intrinsic Value

The intrinsic value of one BSX stock under the Base Case scenario is 69.712 USD. Compared to the current market price of 104.385 USD, Boston Scientific Corp is Overvalued by 33%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BSX Intrinsic Value
69.712 USD
Overvaluation 33%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Boston Scientific Corp

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
BSX
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for BSX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Boston Scientific Corp
NYSE:BSX
US
Health Care
Market Cap
153.9B USD
IPO
May 19, 1992
US
Health Care
Market Cap
153.9B USD
IPO
May 19, 1992
Price
$false
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Boston Scientific Corp
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Boston Scientific Corp

Current Assets 6.9B
Cash & Short-Term Investments 414m
Receivables 2.6B
Other Current Assets 3.9B
Non-Current Assets 32.5B
Long-Term Investments 555m
PP&E 3.7B
Intangibles 23.8B
Other Non-Current Assets 4.4B
Efficiency

Free Cash Flow Analysis
Boston Scientific Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Boston Scientific Corp

Revenue
17.6B USD
Cost of Revenue
-5.5B USD
Gross Profit
12B USD
Operating Expenses
-8.8B USD
Operating Income
3.3B USD
Other Expenses
-1.3B USD
Net Income
2B USD
Fundamental Scores

BSX Profitability Score
Profitability Due Diligence

Boston Scientific Corp's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
57/100
Profitability
Score

Boston Scientific Corp's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

BSX Solvency Score
Solvency Due Diligence

Boston Scientific Corp's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
High Interest Coverage
Long-Term Solvency
64/100
Solvency
Score

Boston Scientific Corp's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BSX Price Targets Summary
Boston Scientific Corp

Wall Street analysts forecast BSX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BSX is 120.092 USD with a low forecast of 84.951 USD and a high forecast of 136.5 USD.

Lowest
Price Target
84.951 USD
19% Downside
Average
Price Target
120.092 USD
15% Upside
Highest
Price Target
136.5 USD
31% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Boston Scientific Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for BSX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

BSX Insider Trading
Buy and sell transactions by insiders

BSX News

Other Videos
What is the Intrinsic Value of one BSX stock?

The intrinsic value of one BSX stock under the Base Case scenario is 69.712 USD.

Is BSX stock undervalued or overvalued?

Compared to the current market price of 104.385 USD, Boston Scientific Corp is Overvalued by 33%.

Back to Top